Skip to main content

PACS and RIS Market To Witness Substantial Growth Due To Growing Popularity of PACS around the World

 


Overview:

A PACS system is a database of medical images and other medical information. It is generally stored in an RIS, though radiologists may choose to view the results directly in PACS. Cloud PACS solutions, however, allow radiologists to access even more information. Moreover, many providers boast of being able to integrate PACS with RIS. However, they are unable to quantify the integration time. RIS and PACS solutions are designed to facilitate interoperability among imaging devices. This is done by creating a standardized communication interface based on DICOM standards. The RIS acts as a master system that provides image management and move control functions. 

Market Dynamics:

The popularity of PACS is growing all over the world and this is anticipated to propel growth of the global PACS and RIS market over the forecast period. PACS help to reduce the physical as well as time barriers linked to regular film-based retrieval, display and distribution of images. For instance, in August 2021, PaxeraHealth, developer of PACS/RIS announced to launch its novel product called PaxexaUltima 8th Generation, which is an AI-based imaging platform that provides AI algorithms for analyzing large data sets.

However, risk of cyber-attacks leading to growing concerns about safety of data in healthcare is likely to obstruct growth of the global PACS and RIS market over the forecast period.

Impact of COVID-19:

The coronavirus outbreak in China affected several industries around the world. Due to the virus outbreak many countries announced nationwide lockdowns. Several market activities including manufacturing, supply of raw materials and distribution activities were disrupted throughout this period. The demand for various products declined during the pandemic which adversely affected growth of several markets including the one in discussion. However, as many countries are lifting lockdown regulations, the market is likely to regain growth.

Key Takeaways:

·         The global PACS and RIS market is expected to grow with a CAGR of 6.8% over the forecast period due to growing number of health care facilities along with products of high value such as orthopedic PACS, cardiology PACS, and more. For instance, in July 2022, The Royal Orthopedic Hospital NHS Foundation Trust announced to deploy a novel cloud-based PACS to offer radiologist intelligent productivity tools.

·         North America is anticipated to witness substantial growth in the global PACS and RIS market over the forecast period. This is due to growing demand for health care and increasing government initiatives for R&D across the region.

·         Major players active in the global PACS and RIS market are Novarad, GENERAL ELECTRIC COMPANY, Cerner Corporation, Koninklijke Philips N.V., ScImage, Inc., FUJIFILM Holdings, PACSHealth, LLC, McKesson Corporation, IBM, Siemens Healthcare Private Limited, INFINITT North America Inc., Agfa-Gevaert Group, Avreo, and Allscripts Healthcare, LLC.

 

 

Labels:

Comments

Post a Comment

Popular posts from this blog

Virology Testing Market Detailed In New Research Report 2023

  Virology testing consist of diagnostic methods that help in early detection of the disease such as hepatitis, influenza, HIV, sexually transmitted disease, RCV, and other viral associated disease. Virology testing examines for detection of viral antigens, nucleic acids, and antibodies in the given sample in order to confirm the presence of particular viral infection. There are more than 100 viral diseases identified. Virology Testing Market- Market Dynamics Virology testing market is projected to witness significant growth during forecast period with rising prevalence of virus originated diseases such as flu, hepatitis, AIDS, and STDs, Ebola, Influenza based viral infections, severe acute respiratory syndrome from coronavirus, hemorrhagic fever etc. across world. Early and fast diagnosis of virus infection is very essential to start treatment course. According to the World Health Organization (WHO), January 2018 factsheet, all types of influenza in combination causes annual...
Post a Comment
Read more

Epidermolysis Bullosa Therapeutics Market Is Booming Worldwide 2023-2028

  Epidermolysis bullosa is a group of rare inherited skin disorders that causes the skin to become very fragile. Any trauma or friction to the skin can cause painful blisters. The symptoms of epidermolysis bullosa include skin that blisters easily, blisters on hands and soles of the feet, thickened skin that may be scarred or change color over time, and thickening of the skin and nails. There are three types of epidermolysis bullosa which includes: ·          Epidermolysis bullosa simplex (EBS) – the most common type, which can range from mild, with a low risk of serious complications to severe ·          Dystrophic epidermolysis bullosa (DEB) – which can range from mild to severe ·          Junctional epidermolysis bullosa (JEB) – a rare form of epidermolysis bullosa that ranges from moderate to severe The type reflects where on the body the blistering ...
Post a Comment
Read more

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Analysis

  A primary driver for this market is the worldwide increase in occurrence of diabetes and cancer, across all age groups. According to the World Health Organization (WHO) 2018 statistics, the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. Moreover according to the World Health Organization cancer factsheet 2018, Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018.  Furthermore, increasing old age population is another driver, which is anticipated to create a high growth scenario for the market. As per the World Population Prospects 2019 revision, the number of people aged 80 years or over is projected to be triple, from 143 million in 2019 to 426 million in 2050. Alternatively, factors restraining the market are complications and risks associated with the treatment including diarrhea, nausea, hair loss, vomiting, severe infections, infertility, and heart complications....
Post a Comment
Read more